Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

8.090 -0.100 (-1.22%)
Streaming Delayed Price Updated: 10:40 AM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 482,337
Open 8.210
Bid (Size) 8.080 (2)
Ask (Size) 8.090 (4)
Prev. Close 8.190
Today's Range 8.030 - 8.320
52wk Range 4.970 - 15.74
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
The AI-powered drug discovery process is expected to grow by a CAGR of 30% by 2030. 
Via Talk Markets
Down About 47% This Year: Is Recursion Pharmaceuticals a Buy on the Dip?
There's a lot to like about the company using automation and artificial intelligence to improve the new drug-discovery process. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
-18.04%
-18.04%
1 Month
+8.44%
+8.44%
3 Month
-1.34%
-1.34%
6 Month
-24.82%
-24.82%
1 Year
-42.71%
-42.71%

More News

Read More
25 Best Artificial Intelligence Stocks to Buy Right Now
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
These 7 AI Stocks Were Major Movers On Monday/Tuesday - Here's Why
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Millionaire-Maker Artificial Intelligence (AI) Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
Via Talk Markets
Is Recursion Pharmaceuticals Stock a Buy?
Via The Motley Fool
1 Reason to Buy Recursion Pharmaceuticals Stock and 2 Reasons to Sell
Via The Motley Fool
3 Healthcare Stocks Injecting AI for Big Gains
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
Via Benzinga
These Nvidia-Backed Artificial Intelligence (AI) Stocks Could Soar 73% to 89% Higher, According to Wall Street
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Nvidia Is Buying Shares of These 5 AI Companies. Should You Do the Same?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
Via InvestorPlace
Why SoundHound AI Stock Lost 22% Last Month
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Via Benzinga
Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
Via Benzinga
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
3 AI Stocks on the Edge of a Massive Surge
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
Via Benzinga
Recursion Announces Proposed Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.